Anti-PD-1 therapy achieves favorable outcomes in HBV-positive non-liver cancer.
Zhou J, Chen G, Wang J, Zhou B, Sun X, Wang J, Tang S, Xing X, Hu X, Zhao Y, Peng Y, Shi W, Zhao T, Wu Y, Zhong H, Hong N, Ruan Z, Zhang Y, Jin W.
Zhou J, et al. Among authors: hong n.
Oncogenesis. 2023 Apr 20;12(1):22. doi: 10.1038/s41389-023-00468-0.
Oncogenesis. 2023.
PMID: 37080999
Free PMC article.